Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and -independent prostate cells.

Prostate tissue is composed of both androgen-dependent and -independent cells. To identify the gene program induced by effectors of apoptosis in both of these cell types, we performed differential hybridization on a complementary DNA library prepared from an androgen-independent prostate cancer cell line, AT-3, exposed to ionomycin. Five distinct complementary DNAs representing ionomycin-inducible genes, designated prostate apoptosis response (par) -1, -2, -3, -4, and -5, were identified. Nucleotide sequencing identified par-1 as the rat homologue of a serum- and oxidative stress-inducible gene, 3CH134/erp/CL100; par-2 as the injury-inducible gene HB-EGF encoding a heparin-binding epidermal growth factor-like growth factor; par-3 as the serum-inducible gene cyr-61; whereas par-4 and par-5 were novel, as judged by a GenBank search. par-1, -3, -4, and -5 were also induced in rat ventral prostate following castration, which causes androgen ablation, leading to apoptosis of androgen-dependent prostate cells. Pretreatment of rats with nifedipine prior to castration abrogated inducible expression of the par genes, indicating that their expression was downstream to Ca2+ elevation. Further characterization of these genes revealed that induction of par-4 is apoptosis specific: it is not induced by effectors of growth stimulation, oxidative stress and necrosis, or growth arrest in prostate cells. Together, par-1, -3, -4, and -5 represent an apoptosis response gene program common to both androgen-dependent and -independent prostate cells. Thus, cell death programs in prostate cells are comprised of genes specifically associated with apoptosis as well as those with multifunctional roles in growth regulation. Since elevation of intracellular Ca2+ is central to apoptosis in many cell types, we predict that par genes will be important components of diverse effector-driven apoptotic pathways.

[1]  J. Guthridge,et al.  Activation-dependent apoptosis in CD4+ T cells during murine AIDS. , 1993, Cellular immunology.

[2]  Lin Chen,et al.  Structure, mapping, and expression of erp, a growth factor-inducible gene encoding a nontransmembrane protein tyrosine phosphatase, and effect of ERP on cell growth , 1993, Molecular and cellular biology.

[3]  Hong Sun,et al.  The growth factor-inducible immediate-early gene 3CH134 encodes a protein-tyrosine-phosphatase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Klagsbrun,et al.  Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Klagsbrun,et al.  Heparin-binding EGF-like growth factor: characterization of rat and mouse cDNA clones, protein domain conservation across species, and transcript expression in tissues. , 1993, Biochemical and biophysical research communications.

[6]  S. Keyse,et al.  Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine phosphatase , 1992, Nature.

[7]  L. Gerschenson,et al.  Apoptosis: a different type of cell death , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  V. Rangnekar,et al.  Interleukin-1-inducible tumor growth arrest is characterized by activation of cell type-specific "early" gene expression programs. , 1992, The Journal of biological chemistry.

[9]  A. Capron,et al.  Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals , 1992, The Journal of experimental medicine.

[10]  J. Ameisen Activation-induced Death by Apoptosis in CD4 + T Cells from Human Immunodeficiency Virus-lnfected Asymptomatic Individuals By Her% Groux,* G6rard Torpier,* Didier Mont6,* Yves Mouton,~ , 1992 .

[11]  L. Lau,et al.  cDNA sequence of a growth factor-inducible immediate early gene and characterization of its encoded protein. , 1992, Oncogene.

[12]  N. Kyprianou,et al.  Programmed death of nonproliferating androgen-independent prostatic cancer cells. , 1991, Cancer research.

[13]  D. Tindall,et al.  Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP. , 1991, Cancer research.

[14]  Gwyn T. Williams Programmed cell death: Apoptosis and oncogenesis , 1991, Cell.

[15]  V. Rangnekar,et al.  Antimitogenic and mitogenic actions of interleukin-1 in diverse cell types are associated with induction of gro gene expression. , 1991, The Journal of biological chemistry.

[16]  R. Gittes Carcinoma of the prostate. , 1991, The New England journal of medicine.

[17]  L. Schwartz,et al.  Gene activation is required for developmentally programmed cell death. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[18]  L. Lau,et al.  Expression of cyr61, a growth factor-inducible immediate-early gene , 1990, Molecular and cellular biology.

[19]  N. Kyprianou,et al.  Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. , 1990, Cancer research.

[20]  V. Rangnekar,et al.  The serum and TPA responsive promoter and intron-exon structure of EGR2, a human early growth response gene encoding a zinc finger protein. , 1990, Nucleic acids research.

[21]  R. Oppenheim,et al.  Naturally occurring and induced neuronal death in the chick embryo in vivo requires protein and RNA synthesis: evidence for the role of cell death genes. , 1990, Developmental biology.

[22]  T. Dexter,et al.  Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis , 1990, Nature.

[23]  N. Kyprianou,et al.  Expression of transforming growth factor-β in the rat ventral prostate during castration-induced programmed cell death , 1989 .

[24]  T. Tadakuma,et al.  Activation of a suicide process of thymocytes through DNA fragmentation by calcium ionophores and phorbol esters. , 1989, Journal of immunology.

[25]  S. Orrenius,et al.  Calcium-dependent killing of immature thymocytes by stimulation via the CD3/T cell receptor complex. , 1989, Journal of immunology.

[26]  F. Berger,et al.  Androgen-regulated gene expression. , 1989, Annual review of physiology.

[27]  D. Wolgemuth,et al.  Cascade induction of c-fos, c-myc, and heat shock 70K transcripts during regression of the rat ventral prostate gland. , 1988, Molecular endocrinology.

[28]  N. Kyprianou,et al.  Activation of programmed cell death in the rat ventral prostate after castration. , 1988, Endocrinology.

[29]  M. Benson,et al.  Calcium channel antagonists delay regression of androgen‐dependent tissues and suppress gene activity associated with cell death , 1988, The Prostate.

[30]  D. A. Greenberg Calcium channels and calcium channel antagonists , 1987, Annals of neurology.

[31]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[32]  J. Tite,et al.  DNA fragmentation: manifestation of target cell destruction mediated by cytotoxic T-cell lines, lymphotoxin-secreting helper T-cell clones, and cell-free lymphotoxin-containing supernatant. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Cohen,et al.  IL-2 addiction: withdrawal of growth factor activates a suicide program in dependent T cells. , 1986, Lymphokine research.

[34]  J. Cohen,et al.  Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. , 1984, Journal of immunology.

[35]  G. Murphy,et al.  LNCaP model of human prostatic carcinoma. , 1983, Cancer research.

[36]  A. Wyllie,et al.  Cell death: the significance of apoptosis. , 1980, International review of cytology.

[37]  C. Lee,et al.  Partial inhibition of castration induced ventral prostate regression with actinomycin D and cycloheximide. , 1978, Investigative urology.

[38]  W. Catalona,et al.  Carcinoma of the prostate: a review. , 1978, The Journal of urology.

[39]  N. J. Heckel Endocrine therapy in the management of prostatic cancer. , 1953, The Journal of clinical endocrinology and metabolism.